MK-4716 drug page Clinical trials

Trials with MK-4716

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
7Countries
250Planned patients

Showing 1–1 of 1

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Recruiting Phase 1 250 patients NCT07247110

Researchers are looking for new ways to treat certain advanced or metastatic solid tumors. The goal of this study is to learn about the safety of MK-4716 and if people tolerate it when taken alone or with other treatments.

United States, Australia, Canada, Chile and 3 more Dec 2025 – Dec 2030 Interventional
Combined with: CetuximabPembrolizumab

Where the recruiting trials are